FDA inspection
Auriga Research Private Limited: FDA inspection ending Feb 6, 2026
FDA inspection 1301886 · Official Action Indicated (OAI) · Bengaluru
Key facts
| Inspection ID | 1301886 |
|---|---|
| Firm | Auriga Research Private Limited |
| FEI number | 3019975128 |
| Address | Plot No 136, 6th Cross |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2026 |
| Inspection end date | Feb 6, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 730694 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data